We found that primary leukemia cells from CLL patients have significantly higher levels of CXCR4 expression compared with normal B cells and that high-risk prognostic factors do not influence the level of expression of this chemokine receptor. Here, CXCR4 is linked to B-cell chronic lymphocytic leukemia.